Cardiovascular diseases represent the main causes of morbidity and mortality in patients
with chronic kidney disease (CKD). According to a well-established classification …

The authors investigated 3 important areas related to the clinical use of left ventricular mass
(LVM): accuracy of assessments by echocardiography and cardiac magnetic resonance …

Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to
cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of …

Background—Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone. In
chronic kidney disease (CKD), circulating FGF-23 levels are markedly elevated and …

Chronic kidney disease (CKD) and ESRD, treated with conventional hemo-or peritoneal
dialysis are both associated with a high prevalence of an increase in left ventricular mass …

Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left
ventricular hypertrophy progression. Background Regression of left ventricular hypertrophy …

Volume overload in haemodialysis (HD) patients associates with hypertension and cardiac
dysfunction and is a major risk factor for all-cause and cardiovascular mortality in this …

Background: Most patients with chronic kidney disease (CKD) develop cardiovascular
complications. Natriuretic peptides are novel markers that can be used to identify and …

Objectives: This study sought to investigate clinical and echocardiographic correlates of the
lung comets score. Background: Early detection of pulmonary congestion is a fundamental …

Left ventricular hypertrophy is an important risk factor in cardiovascular disease and
echocardiography has been widely used for diagnosis. Although an adequate methodologic …